Reducing dampness and turbidity

"Reducing dampness and turbidity" is a pharmacological classification and therapeutic principle within Traditional Chinese Medicine (TCM) rather than a discrete molecular target such as a protein, enzyme, or receptor. In the context of TCM theory, 'dampness' and 'turbidity' refer to the accumulation of pathological fluids and metabolic waste products resulting from systemic dysfunction, particularly of the Spleen and Kidney systems. Clinically, this principle is applied to treat conditions that modern medicine identifies as metabolic disorders, including hyperlipidemia, hyperuricemia, and obesity. Research into herbs that 'reduce dampness' often reveals multi-target effects on aquaporins, lipid transporters, and inflammatory cytokines, but the term itself describes a clinical outcome rather than a specific binding site. For a biotech analyst, it is important to note that this is a holistic therapeutic strategy often utilized in the development of botanical drugs or multi-component formulations. Because it lacks a specific UniProt ID or a single defined molecular structure, it is considered an 'incorrect' target entry in the context of canonical molecular drug discovery.

Other names

Hua Shi ZhuoResolving dampness and turbidityTransforming dampness and turbidityEliminating dampness and turbidityExpelling dampness and turbidity

Traditional Chinese Medicine therapeutic principle focused on promoting diuresis, improving splenic transportive function, and clearing accumulated pathological metabolites through various physiological pathways.